Sign in
Taking people in United StatesNo phase

Tests a blood pressure support tool to help protect thinking skills

Tests a decision support tool and team care for older adults with high blood pressure.

Key facts

Who runs it
University of Texas Southwestern Medical Center
Where
Dallas, United StatesSee the site
Trial code
Registry title
Preventing Cognitive Decline by Reducing BP Target Trial
Status
Recruiting
People taking part
4,000 people, planned
Started
11 Jul 2022
Planned end
31 Aug 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Clinical Support Decision Tool
Record updated
3 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people aged 70 or older who have had high blood pressure in the past 24 months. It tests whether special blood pressure care lowers the chance of memory problems.

Age
70 years or older
Sex
All sexes can join.
Disease stage
High blood pressure: at least 1 reading of SBP >= 130 or DBP >=80 in the 24 months before joining.
Earlier treatment
A clinic visit with a primary care provider in the last 24 months.

Main reasons for not taking part

  • Blood pressure consistently below 130/80 mmHg
  • Dementia, Alzheimer's disease or significant neurological disease
  • Major and unstable heart disease
  • Chronic kidney disease stage 5 or ESKD
  • Chemotherapy

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • High BP defined as at least 1 BP readings of SBP >= 130 or DBP >=80 during the 24 months prior to enrollment
  • Clinic visit with primary care provider within the last 24 months
  • Ability to write and speak English or Spanish
  • 70 years of age or older
  • Ability to understand and willingness to provide informed consent
  • Owns a smartphone

Who cannot take part

  • Chemotherapy
  • Presence of dementia, Alzheimer's disease, or significant neurological disease
  • Major and unstable heart disease (e.g., acute heart failure (systolic or diastolic), acute on chronic heart failure (systolic or diastolic), acute coronary syndrome or cardiac arrest, liver or renal transplantation
  • Chronic kidney disease stage 5 or ESKD
  • Any conditions judged by the medical providers to contraindicate participation due to risk to patient safety or lack of adherence
  • Under 70 years of age
  • Blood pressure consistently <130/80 mmHg
  • Inability to write or speak English or Spanish
  • Expected life expectancy under a year

Where in United States

  • UT Southwestern Medical CenterDallas, United StatesContact: Miguel Vazquez, MDTaking people

About the trial

What the trial wants to find out

The PCOT study is a multi-site randomized trial of patients 70 years or older with high BP. The main goal of the study Preventing Cognitive Decline by Reducing BP Target Trial (PCOT) is to conduct a large pragmatic clinical trial (PCT) to test the hypothesis that patients who receive care with a combination of clinical decision support (CDS) and team-based care delivered in primary care practices will have better blood pressure control and a lower incidence of mild cognitive impairment and dementia than patients receiving usual medical care. Patients will be recruited from UT Southwestern Medical Center and Parkland Health \& Hospital System.

The 2 groups in the trial

  • Intervention ArmTreatment being tested

    Home BP data will be averaged each month via OmronConnect app on the patients' smartphone, which is programmed to send home BP readings to MyChart via Apple or Google Health.Participants whose home blood pressure reading average is systolic ≥ 130 and diastolic ≥ 80 will trigger the CDS (Clinical Decision Support) tool to assist their physicians with their blood pressure management. Study Team will not be involved in treatment decision making, it will be determined by subject's treating physician. .

    Treatment: Clinical Support Decision Tool

  • Usual Care ArmNo study treatment, for comparison

    Physicians will continue to make decisions about the participant's blood hypertension management as usual without the CDS tool.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Preventing Cognitive Decline by Reducing BP Target Trial
Plain-language title
Tests a blood pressure support tool to help protect thinking skillsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
3 December 2025